Terms: = Lymphoma AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Clinical Outcome
12 results:
1. STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell lymphoma.
Risinskaya N; Mangasarova Y; Nikulina E; Kozhevnikova Y; Chabaeva J; Yushkova A; Magomedova A; Kulikov S; Julhakyan H; Kravchenko S; Sudarikov A
Curr Oncol; 2022 May; 29(5):3449-3459. PubMed ID: 35621668
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA LINC00467 contributes to osteosarcoma growth and metastasis through regulating HMGA1 by directly targeting miR-217.
Ma HZ; Wang J; Shi J; Zhang W; Zhou DS
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5933-5945. PubMed ID: 32572906
[TBL] [Abstract] [Full Text] [Related]
3. Targetable molecular alterations in congenital glioblastoma.
Gilani A; Donson A; Davies KD; Whiteway SL; Lake J; DeSisto J; Hoffman L; Foreman NK; Kleinschmidt-DeMasters BK; Green AL
J Neurooncol; 2020 Jan; 146(2):247-252. PubMed ID: 31875306
[TBL] [Abstract] [Full Text] [Related]
4. Impact of FLT3 Receptor (CD135) Detection by Flow Cytometry on clinical outcome of Adult Acute Myeloid Leukemia Patients.
Kandeel EZ; El Sayed G; Elsharkawy N; Eldin DN; Nassar HR; Ibrahiem D; Amin R; Hanafi M; Khalil M; Kamel A
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):541-547. PubMed ID: 29907544
[TBL] [Abstract] [Full Text] [Related]
5. clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.
Gao N; Yu WZ; Guo NJ; Wang XX; Sun JR
Leuk Lymphoma; 2017 Jun; 58(6):1394-1402. PubMed ID: 27736291
[TBL] [Abstract] [Full Text] [Related]
6. Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
Aricò A; Ferraresso S; Bresolin S; Marconato L; Comazzi S; Te Kronnie G; Aresu L
PLoS One; 2014; 9(11):e111817. PubMed ID: 25372838
[TBL] [Abstract] [Full Text] [Related]
7. Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-kit, FLT3, and JAK2 mutations on clinical outcome.
Marková J; Marková J; Trnková Z; Michková P; Maaloufová J; Starý J; Cetkovský P; Schwarz J
Leuk Lymphoma; 2009 Sep; 50(9):1448-60. PubMed ID: 19603346
[TBL] [Abstract] [Full Text] [Related]
8. Molecular detection of BCR/ABL fusion gene in Saudi acute lymphoblastic leukemia patients.
El-Sissy A; El-Mashari M; Bassuni W; El-Swaayed A
J Egypt Natl Canc Inst; 2006 Jun; 18(2):109-16. PubMed ID: 17496935
[TBL] [Abstract] [Full Text] [Related]
9. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract] [Full Text] [Related]
10. Low molecular weight protein of Helicobacter pylori and its relation to gastroduodenal diseases.
Kuo CH; Wu DC; Lu CY; Su YC; Yu FJ; Lee YC; Wu IC; Lin SR; Liu CS; Jan CM; Wang WM
Hepatogastroenterology; 2003; 50(52):897-901. PubMed ID: 12845945
[TBL] [Abstract] [Full Text] [Related]
11. Expression of the C-kit receptor (cd117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
[TBL] [Abstract] [Full Text] [Related]
12. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract] [Full Text] [Related]
